Skip to main content
Premium Trial:

Request an Annual Quote

Genoway Licenses Bluebird's Genetic Modification Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biotech Genoway said today it has licensed technology from Bluebird Bio to genetically modify rodents.

The license grants Genoway exclusive worldwide rights to Bluebird's RCME technology, which combines a recombinase system with genetic modification, enabling the introduction of a DNA sequence at a specific locus. The technology was developed at the Massachusetts Institute of Technology.

According to Genoway, based in Lyon, France, targeted insertion has now replaced most classic transgenic models, and RCME is an essential tool in the making of knock-in rodents.

Financial and other terms of the deal were not disclosed.

Bluebird develops gene therapies and has offices in Cambridge, Mass., and Paris. Genoway develops genetically modified and research models for the bio-pharmaceutical, chemical, agrochemical, and food industry.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.